Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis. - Wikidata - awgldk - TriplyDB

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.

http://www.wikidata.org/entity/Q37327436

about

Effects of RNA interference-mediated gene silencing of VEGF on the ultrafiltration failure in a rat model of peritoneal dialysis.Nebivolol, But Not Metoprolol, Treatment Improves Endothelial Fibrinolytic Capacity in Adults With Elevated Blood Pressure.

P2860

Q41564889-288E0356-57E4-4987-9DCD-A1BC3205D116 Q47120708-7C821E3C-B49B-4055-A20E-E58DE51C9FFA

P2860

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.

http://www.wikidata.org/entity/Q37327436

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nebivolol, a β1-adrenergic blo ...... ed during peritoneal dialysis.

@en

Nebivolol, a β1-adrenergic blo ...... ed during peritoneal dialysis.

@nl

type

label

Nebivolol, a β1-adrenergic blo ...... ed during peritoneal dialysis.

@en

Nebivolol, a β1-adrenergic blo ...... ed during peritoneal dialysis.

@nl

prefLabel

Nebivolol, a β1-adrenergic blo ...... ed during peritoneal dialysis.

@en

Nebivolol, a β1-adrenergic blo ...... ed during peritoneal dialysis.

@nl

P1433

Q37327436-B8423F89-CFA4-4E22-83DF-B932498833BB

P1476

Q37327436-20D8EC54-5BE6-40C9-8260-3ACEC43870C9

P2093

Q37327436-00E5F4BE-71F6-4942-965A-D5C8B4697E63

Q37327436-2386AF0A-648A-4AF1-9A67-7DB1E219A3F7

Q37327436-45D5DDD9-2D33-4BC1-8BC9-A2EBD51CFFA0

Q37327436-59145EBB-8E4A-4E00-AAD2-DD5FA2289465

Q37327436-76CB2A3B-7855-413B-AEE1-BEFC1B8949F8

Q37327436-8C673166-FDCE-4EC4-A6D2-52DCA3537AE2

Q37327436-9508CEB8-5B8D-4FB4-A2BA-8B33423028F5

Q37327436-9C988DEF-F284-4A16-8A68-11351C51E760

Q37327436-BF31EAA8-A6C0-4286-A446-D9540C166C2B

Q37327436-BF60219B-E27D-4D8D-BAA7-2A9739189CB2

P2860

Q37327436-011083EF-2360-48D5-91A5-4CCFCF0C050C

Q37327436-0414F046-A546-466E-8975-07FEF4C246F7

Q37327436-1286867E-3156-49BE-91B1-CD6B2DE413AA

Q37327436-137D6174-4FCA-4420-BCEC-51FA4D06D762

Q37327436-151161F8-EBDC-4430-BD42-C063E0735287

Q37327436-23E7B1ED-F183-41FA-9A70-B102DD448F4F

Q37327436-240BE462-5B74-4EF7-AC8C-9B4FD3745E16

Q37327436-247F82C8-A59D-4E8B-9D50-48B387037B4C

Q37327436-296B01AD-0D13-4D37-8DFF-AA12EA16D2A3

Q37327436-2AF3C306-4FF4-4ED6-9666-F6520BBF1144

P304

Q37327436-816D24C8-5638-4B6B-BCBE-9F9AC3502FF9

P31

Q37327436-C58FBA06-324B-432D-88FD-6D061589C4CD

P356

Q37327436-B6F9F830-7FA3-43B2-A177-C25EF0000F66

P407

Q37327436-565D5FDB-058B-4DC9-81BF-BB0AF73AC40C

P433

Q37327436-0AEB00FD-7900-4A99-BB0F-0BA92C6375CE

P478

Q37327436-96F19670-ACF9-47A4-A339-A6CC2F927441

P50

Q37327436-C2F582D2-BFAC-4C4C-B92D-9ABB9B91460C

Q37327436-D19FC514-7544-4AFF-A45D-F2ADE18D7003

Q37327436-EF0767F5-9C11-4968-BB44-26F603E7EA01

P577

Q37327436-21123791-5D95-46ED-8DA5-BA2884E6889F

P698

Q37327436-A5419A83-BA1F-4517-ABE6-BBAA4295ABE8

P921

Q37327436-7F91E9B7-E114-4672-8191-26183D21E1BA

P932

Q37327436-E9DE1639-B3B7-4115-86C3-EE7C28C9036B

P356

ONCOTARGET.8780

P1433

P1476

Nebivolol, a β1-adrenergic blo ...... ed during peritoneal dialysis.

@en

P2093

Abelardo Aguilera

http://www.w3.org/2001/XMLSchema#string

Anna Rita Aguirre

http://www.w3.org/2001/XMLSchema#string

Emilio González Parra

http://www.w3.org/2001/XMLSchema#string

Georgios Liappas

http://www.w3.org/2001/XMLSchema#string

Gloria Del Peso

http://www.w3.org/2001/XMLSchema#string

Hugo Abensur

http://www.w3.org/2001/XMLSchema#string

José A Sánchez Tomero

http://www.w3.org/2001/XMLSchema#string

Juan Manuel Acedo

http://www.w3.org/2001/XMLSchema#string

Laura García Ramírez

http://www.w3.org/2001/XMLSchema#string

María A Bajo

http://www.w3.org/2001/XMLSchema#string

P2860

A Review of Nebivolol Pharmacology and Clinical Evidence

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis

Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells.

Pathophysiology of peritoneal membrane failure.

Treatment with a highly selective β₁ antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats.

Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.

The favorable kinetics and balance of nebivolol-stimulated nitric oxide and peroxynitrite release in human endothelial cells.

P304

30133-30146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.8780

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Guadalupe T González-Mateo

Manuel López Cabrera

P577

2016-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27102153

http://www.w3.org/2001/XMLSchema#string

P921

P932

5058669

http://www.w3.org/2001/XMLSchema#string